Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Cabaletta Bio, Inc. (CABA)
|
Add to portfolio |
|
|
|
| Price: |
$3.92
| | Metrics |
| OS: |
39.8
|
M
| |
-33
|
% ROE
|
| Market cap: |
$156
|
M
| |
|
|
|
Net cash:
|
$128
|
M
| |
$3.22
|
per share
|
|
EV:
|
$28
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($7.24)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Revenue growth | | | -100.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | 0.0% | |
| Selling, general and administrative | 54.1 | 46.3 | | | |
| Research and development | | | 21.4 | 11.7 | 4.5 |
| General and administrative | | | 12.5 | 7.0 | 1.7 |
| EBIT | 0.0 | 0.0 | -33.8 | -18.7 | -6.2 |
| EBIT margin | | | | -18498.0% | |
| Pre-tax income | -53.0 | -46.3 | -33.3 | -16.9 | -12.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -53.0 | -46.3 | -33.3 | -22.3 | -12.2 |
| Net margin | | | | -22048.5% | |
| |
| Diluted EPS | ($8.92) | ($1.80) | ($1.44) | ($4.07) | ($6.87) |
| Shares outstanding (diluted) | 5.9 | 25.7 | 23.2 | 5.5 | 1.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|